Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MRE3008F20 is a species-selective and potent adenosine A3 receptor (AA3R) antagonist that inhibits Cl-IB-MECA-induced cAMP production and can be used in glaucoma and asthma studies.CAS 번호13483-88-88-9
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 15,000 | |||
2 mg | 在庫あり | ¥ 21,500 | |||
5 mg | 在庫あり | ¥ 35,500 | |||
10 mg | 在庫あり | ¥ 52,500 | |||
25 mg | 在庫あり | ¥ 89,000 | |||
50 mg | 在庫あり | ¥ 130,500 |
説明 | MRE3008F20 is a species-selective and potent adenosine A3 receptor (AA3R) antagonist that inhibits Cl-IB-MECA-induced cAMP production and can be used in glaucoma and asthma studies.CAS 번호13483-88-88-9 |
ターゲット&IC50 | AA3 receptor (T lymphocytes):5 nM |
分子量 | 432.44 |
分子式 | C21H20N8O3 |
CAS No. | 252979-43-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MRE3008F20 252979-43-4 GPCR/G Protein Neuroscience cAMP Adenosine Receptor MRE-3008F20 Inhibitor inhibitor inhibit